192 related articles for article (PubMed ID: 15386797)
1. FISHing and beyond in urinary cytology.
Dahmoush L; Cohen MB
Diagn Cytopathol; 2004 Oct; 31(4):201. PubMed ID: 15386797
[No Abstract] [Full Text] [Related]
2. Vysis UroVysion for the detection of urothelial carcinoma.
Halling KC
Expert Rev Mol Diagn; 2003 Jul; 3(4):507-19. PubMed ID: 12877389
[TBL] [Abstract][Full Text] [Related]
3. Comparative diagnostic value of urine cytology, UBC-ELISA, and fluorescence in situ hybridization for detection of transitional cell carcinoma of urinary bladder in routine clinical practice.
May M; Hakenberg OW; Gunia S; Pohling P; Helke C; Lübbe L; Nowack R; Siegsmund M; Hoschke B
Urology; 2007 Sep; 70(3):449-53. PubMed ID: 17688921
[TBL] [Abstract][Full Text] [Related]
4. Multiprobe fluorescence in situ hybridization (UroVysion) for the detection of urothelial carcinoma - FISHing for the right catch.
Bubendorf L
Acta Cytol; 2011; 55(2):113-9. PubMed ID: 21325794
[TBL] [Abstract][Full Text] [Related]
5. UroVysion multiprobe FISH in urinary cytology.
Bubendorf L; Grilli B
Methods Mol Med; 2004; 97():117-31. PubMed ID: 15064489
[No Abstract] [Full Text] [Related]
6. The value of phase contrast microscopy for urinary cytology, reliability and pitfalls.
de Voogt HJ; Beyer-Boon ME; Brussee JM
Acta Cytol; 1975; 19(6):542-6. PubMed ID: 1108567
[No Abstract] [Full Text] [Related]
7. Combined morphologic and fluorescence in situ hybridization analysis of voided urine samples for the detection and follow-up of bladder cancer in patients with benign urine cytology.
Daniely M; Rona R; Kaplan T; Olsfanger S; Elboim L; Freiberger A; Lew S; Leibovitch I
Cancer; 2007 Dec; 111(6):517-24. PubMed ID: 17963263
[TBL] [Abstract][Full Text] [Related]
8. [Meta-analysis of fluorescence in situ hybridization and cytology for diagnosis of bladder cancer].
Yang MG; Zhao XK; Hou Y; Xiao N
Ai Zheng; 2009 Jun; 28(6):655-62. PubMed ID: 19635207
[TBL] [Abstract][Full Text] [Related]
9. Urinary bladder tumor markers.
Lokeshwar VB; Selzer MG
Urol Oncol; 2006; 24(6):528-37. PubMed ID: 17138134
[TBL] [Abstract][Full Text] [Related]
10. FISH--a new noninvasive method for the diagnosis of urinary bladder carcinomas.
Lübbe L; Nowack R; May M; Ullmann K; Gunia S; Kaufmann O; Hakenberg O; Muche J; Hoschke B
Clin Lab; 2004; 50(7-8):395-402. PubMed ID: 15330506
[TBL] [Abstract][Full Text] [Related]
11. Urinary cytology for carcinoma in situ of the urinary bladder.
Rosa B; Cazin M; Dalian G
Acta Cytol; 1985; 29(2):117-24. PubMed ID: 3856981
[TBL] [Abstract][Full Text] [Related]
12. Use of a multitarget fluorescence in situ hybridization assay to diagnose bladder cancer in patients with hematuria.
Sarosdy MF; Kahn PR; Ziffer MD; Love WR; Barkin J; Abara EO; Jansz K; Bridge JA; Johansson SL; Persons DL; Gibson JS
J Urol; 2006 Jul; 176(1):44-7. PubMed ID: 16753364
[TBL] [Abstract][Full Text] [Related]
13. Utility of a multiprobe fluorescence in situ hybridization assay in the detection of superficial urothelial bladder cancer.
Marín-Aguilera M; Mengual L; Ribal MJ; Burset M; Arce Y; Ars E; Oliver A; Villavicencio H; Algaba F; Alcaraz A
Cancer Genet Cytogenet; 2007 Mar; 173(2):131-5. PubMed ID: 17321328
[TBL] [Abstract][Full Text] [Related]
14. UroVysion compared with cytology and quantitative cytology in the surveillance of non-muscle-invasive bladder cancer.
Moonen PM; Merkx GF; Peelen P; Karthaus HF; Smeets DF; Witjes JA
Eur Urol; 2007 May; 51(5):1275-80; discussion 1280. PubMed ID: 17084511
[TBL] [Abstract][Full Text] [Related]
15. Comparison of NMP22 BladderChek test and urine cytology for the detection of recurrent bladder cancer.
Kumar A; Kumar R; Gupta NP
Jpn J Clin Oncol; 2006 Mar; 36(3):172-5. PubMed ID: 16520358
[TBL] [Abstract][Full Text] [Related]
16. The role of urinary cytology for detection of bladder cancer.
Planz B; Jochims E; Deix T; Caspers HP; Jakse G; Boecking A
Eur J Surg Oncol; 2005 Apr; 31(3):304-8. PubMed ID: 15780568
[TBL] [Abstract][Full Text] [Related]
17. Bladder cancer detection using FISH (UroVysion assay).
Halling KC; Kipp BR
Adv Anat Pathol; 2008 Sep; 15(5):279-86. PubMed ID: 18724101
[TBL] [Abstract][Full Text] [Related]
18. Urinary CYFRA 21.1 is not a useful marker for the detection of recurrences in the follow-up of superficial bladder cancer.
Fernandez-Gomez J; Rodríguez-Martínez JJ; Barmadah SE; García Rodríguez J; Allende DM; Jalon A; Gonzalez R; Alvarez-Múgica M
Eur Urol; 2007 May; 51(5):1267-74. PubMed ID: 17207912
[TBL] [Abstract][Full Text] [Related]
19. [Urinary cytology in symptomatic subjects: cyto-histological comparison in 124 cases].
Pisa R; Piubello Q; Scarpa A; Novelli P; Baiocco R; Pea M; Marino F
Pathologica; 1985; 77(1050):409-16. PubMed ID: 3834373
[No Abstract] [Full Text] [Related]
20. Diagnosis of bladder cancer: a challenge for urine cytology by tumor markers?
Ray VH
Am Clin Lab; 1999; 18(1):21. PubMed ID: 10351121
[No Abstract] [Full Text] [Related]
[Next] [New Search]
